Molina, JT, Hernández-Cruz, B, Corominas, H. Initial Treatment with Biological Therapy in Rheumatoid Arthritis. Journal of Clinical Medicine. 2024; 13(1)DOI:10.3390/jcm13010048. PMID:38202055. IF:2.900(Q1/2D).

Clotet-Vidal, S, Prieto, MES, Llorach, PD, Gutiérrez, AS, Pou, JC, Bonafonte, OHT. Malnutrition, Functional Decline, and Institutionalization in Older Adults after Hospital Discharge Following Community-Acquired Pneumonia. Nutrients. 2024; 16(1)DOI:10.3390/nu16010011. PMID:38201841. IF:5.000(Q1/2D).

Figueras, I, Feito, M, García-Bustinduy, M, Monte-Boquet, E, Ros, S, Zaragoza, V, De Tena, AL, De Frutos, FJO. A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:10.2340/actadv.v104.18255. PMID:38566531. IF:3.700(Q1/2D).

Palones E., García-Rivero J.L., Cisneros C., Almonacid-Sánchez C., Pérez-de Llano L., Plaza V., Crespo-Lessmann A.. Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(3)DOI:10.1016/j.arbres.2024.01.002. PMID:38290898. IF:9.200(Q1/1D).

Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.007. PMID:38040573. IF:9.200(Q1/1D).

Valverde-Monge M., Sánchez-Carrasco P., Betancor D., Barroso B., Rodrigo-Muñoz J.M., Mahillo-Fernández I., Arismendi E., Bobolea I., Cárdaba B., Cruz M.J., Del Pozo V., Domínguez-Ortega J., González-Barcala F.J., Olaguibel J.M., Luna-Porta J.A., Martínez-Rivera C., Mullol J., Muñoz X., Peleteiro-Pedraza L., Picado Valles C., Plaza V., Quirce S., Rial M.J., Soto-Retes L., Valero A., Sastre J.. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.011. PMID:38042707. IF:9.200(Q1/1D).

Cano-Jiménez, E, Gómez, AV, Segovia, EV, Barrenechea, MA, Torres, JS, Francesqui, J, Carroz, KP, Solis, AJS, Fernández, OA, González, ABL, Bordas-Martinez, J, Cesar, EC, Vilarnau, EB, Villegas, DC, Pardessus, AR, Fernández, CG, Moyano, MG, Gajate, AU, Hortas, AB, Molina-Molina, M. Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study. Erj Open Research. 2024; 10(1)DOI:10.1183/23120541.00405-2023. PMID:38410707. IF:4.000(Q1/2D).

Romero, BR, Torrubiano, IV, Juan, JM, Frades, SH, Pallares, JP, Ruiz, VP, Pérez, AW, Ramos, HC, Viedma, EC. Ultrasound in the Study of Thoracic Diseases: Innovative Aspects. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.009. PMID:37996336. IF:9.200(Q1/1D).

de-Torres, JP, Casanova, C, Marín, JM, Cabrera, C, Marín, M, Ezponda, A, Cosio, BG, Martínez, C, Solanes, I, Fuster, A, Calle, M, Gotera, C, Feu-Collado, N, Marin, A, Alcaide, AB, Sangro, M, Bastarrika, G, Celli, BR. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.002. PMID:37925245. IF:9.200(Q1/1D).

Betancor, D, Otal, M, Olaguibel, JM, Rodrigo-Muñoz, JM, Puebla, MJA, Arismendi, E, Barranco, P, Barroso, B, Bobolea,, Cárdaba, B, Cruz, MJ, Curto, E, Del Pozo,, Domínguez-Ortega, J, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza,, Quirce, S, Rial, MJ, Roibás-Veiga,, Soto-Retes, L, Valero, A, Valverde-Monge, M, Sastre, J. Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(3)DOI:10.18176/jiaci.0966. PMID:38888581. IF:4.800(Q1/1D).

Plaza, V, Trigueros, JA, Carretero, JA, Arranz, IO, Chicote, JMV, Sánchez, CA, Tomás, JB, Serrano, CC, Juncal, LD, Domínguez-Ortega, J, Rivero, JF, Campos, JGS, Fernández, EM, Martinez, S, Lacomba, JM, Quirce, S. Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(4)DOI:10.18176/jiaci.0975. PMID:38334050. IF:4.800(Q1/1D).

Shachar, SS, Korzets, Y, Shepshelovich, D, Zlothover, N, Amir, E, Tibau, A, Goldvaser, H. Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review. CANCER TREATMENT REVIEWS. 2024; 122DOI:10.1016/j.ctrv.2023.102666. PMID:38064877. IF:10.500(Q1/1D).

Grünwald, V, Powles, T, Eto, M, Kopyltsov, E, Rha, SY, Porta, C, Motzer, R, Hutson, TE, Méndez-Vidal, MJ, Hong, SH, Winquist, E, Goh, JC, Maroto, P, Buchler, T, Takagi, T, Burgents, JE, Perini, R, He, C, Okpara, CE, McKenzie, J, Choueiri, TK. Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms. Onkourologiya. 2024; 20(1)DOI:10.17650/1726-9776-2024-20-1-24-35. PMID:. IF:(Q/D).

León X., Neumann E., Holgado A., Vásquez R., Pujol A., Quer M.. Oncological results of salvage treatment in patients with oropharynx carcinoma treated with radiotherapy. Acta Otorrinolaringologica Espanola. 2024; 75(1)DOI:10.1016/j.otorri.2023.01.002. PMID:. IF:(Q/D).

Benjumea, C, Navarro, F, Tarrés, CA. Improving the diagnosis of urinary tract infections by the use of enriched media and a 48-hour incubation period. JOURNAL OF MEDICAL MICROBIOLOGY. 2024; 73(6)DOI:10.1099/jmm.0.001846. PMID:38935081. IF:2.000(Q3/8D).

Habib, AA, Sacconi, S, Antonini, G, Cortés-Vicente, E, Grosskreutz, J, Mahuwala, ZK, Mantegazza, R, Pascuzzi, RM, Utsugisawa, K, Vissing, J, Vu, T, Wiendl, H, Boehnlein, M, Greve, B, Woltering, F, Bril, V. Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study. Therapeutic Advances in Neurological Disorders. 2024; 17DOI:10.1177/17562864241273036. PMID:39297052. IF:4.100(Q1/2D).

Lugogo, NL, Heffler, E, Plaza, V, Hilberg, O, Xia, CM, Nash, S, Pandit, N, Jacob-Nara, JA, Sacks, HJ, Rowe, PJ, Deniz, Y, Hardin, M, Soler, X. Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry. Journal of Asthma and Allergy. 2024; 17DOI:10.2147/JAA.S451689. PMID:38860029. IF:3.000(Q2/4D).

Gonzalez-Recio, P, Crossin, R, Donat, M, Palma, D, Caballero, DG, Moreno-Garcia, S, Guerras, JM, Belza, MJ. Chemsex Session Typologies and Associated Sociodemographic Factors in Sexual Minority Men: Latent Class Analysis From a Cultural Perspective Using a Cross-Sectional Survey. JMIR Public Health and Surveillance. 2024; 10DOI:10.2196/60012. PMID:39331536. IF:3.900(Q1/2D).

Santero M., de Mas J., Rifà B., Clavero I., Rexach I., Cosp, XB. Assessing the methodological strengths and limitations of the Spanish Society of Medical Oncology (SEOM) guidelines: a critical appraisal using AGREE II and AGREE-REX tool.. Clinical & Translational Oncology. 2024; https://ddd.uab.cat/recor(1)DOI:10.1007/s12094-023-03219-0. PMID:37368198. IF:2.500(Q2/5D).

Borray-Escalante, NA, Nuñez-Tobajas, Z, Batllori, X, Santos, D, Clavell, J, Domènech, J, Arroyo, L, Uribe, F, Rodríguez-Pastor, R, Pascual, J, Carrillo-Ortiz, JG, Molina, B, del Moral, JC, Montalvo, T, Cardador, L, Hatchwell, B, Senar, JC. Rewinding the invasion history of monk parakeets in Barcelona city: 1976-2022. ANIMAL BIODIVERSITY AND CONSERVATION. 2024; 47(1)DOI:10.32800/abc.2024.47.0101. PMID:. IF:1.400(Q3/7D).